Antimicrobial peptide production in response to gut microbiota imbalance.

Cardoso, Marlon H et al.·Peptides·2022·
RPEP-060312022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Antimicrobial peptide production in response to gut microbiota imbalance.
Published In:
Peptides, 157, 170865 (2022)
Database ID:
RPEP-06031

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-06031·https://rethinkpeptides.com/research/RPEP-06031

APA

Cardoso, Marlon H; Meneguetti, Beatriz T; Oliveira-Júnior, Nelson G; Macedo, Maria L R; Franco, Octávio L. (2022). Antimicrobial peptide production in response to gut microbiota imbalance.. Peptides, 157, 170865. https://doi.org/10.1016/j.peptides.2022.170865

MLA

Cardoso, Marlon H, et al. "Antimicrobial peptide production in response to gut microbiota imbalance.." Peptides, 2022. https://doi.org/10.1016/j.peptides.2022.170865

RethinkPeptides

RethinkPeptides Research Database. "Antimicrobial peptide production in response to gut microbio..." RPEP-06031. Retrieved from https://rethinkpeptides.com/research/cardoso-2022-antimicrobial-peptide-production-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.